Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Carmen Arango"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Luis Curbelo-Alfonso, Ariadna Méndez-Rosabal, Ramón del Castillo-Bahi, Roberto Esperón-Noa, Elía Gracia-Medina, Vivian Diéguez-Rodríguez, María E. Faxas-García, Anamary Suárez-Reyes, Pilar Soto-Pardeiro, Griselda Torres-López, Carlos A. Villegas-Valverde, María del Carmen Arango-Prado
Publikováno v:
MEDICC Review. 24:26
Immunity in cancer patients is modified both by the cancer itself and by oncospecific treatments. Whether a patient's adaptive immunity is impaired depends on their levels of naive lymphocytes and other cell populations. During the COVID-19 pandemic,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15a6c4237a096abac16225b800793601
https://doi.org/10.37757/mr2022.v24.n2.5
https://doi.org/10.37757/mr2022.v24.n2.5
Autor:
Carmen Arango Chamorro
Publikováno v:
Revista Atlántida, Iss 4 (2012)
En este artículo se expone una experiencia de investigación cualitativa en el desarrollo del programa de la asignatura trabajo social con comunidades, en la titulación del Grado de Trabajo Social 2012. Dicha experiencia se realiza en el tercer cur
Externí odkaz:
https://doaj.org/article/5798d855805944b2a182866336292e68
Autor:
Pedro Inocente Mas Bermejo, Maria del Carmen Arango Prado, Rosa Maria Ortiz Reyes, Ania Torres Pombert, Fernando Chuecas, Marcela Cortés‐Jofré, Iraida Caballero Aguirrechu, Rolando Uranga, Cecilia Pacheco
Publikováno v:
Cochrane Database Syst Rev
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the effectiveness and safety of therapeutic vaccines for people with advanced non‐small cell lung cancer (non‐irradiatable stage IIIB and stage IV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::122319a1d6223d9ff26d3c48d5979f20
https://europepmc.org/articles/PMC6673723/
https://europepmc.org/articles/PMC6673723/
Autor:
María del Carmen Arango, Santiago Quintero, Adanays Calvo, Adriana Carr, José M. Vázquez, Xiomara Escobar, Debora Danta, Griselda Torres, Tania Lahera, Charles E. Rengifo
Publikováno v:
Journal of Oncology
Journal of Oncology, Vol 2014 (2014)
Journal of Oncology, Vol 2014 (2014)
Purpose. To assess the prognostic role of 14F7 Mab immunoreactivity, against N-Glycolyl GM3 ganglioside, in patients with colon cancer (CC) and to evaluate the relationship between its expression and clinicopathological features.Methods. Paraffin-emb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fef483a8c8107d8280dd81036ba7132a
https://doi.org/10.1155/2014/482301
https://doi.org/10.1155/2014/482301
Autor:
Tania Carmenate Portilla, José A Sánchez-Villanueva, ro Linchenat Lambert, Karen López Miguel, María del Carmen Arango Prado, Alej, Carlos Agustín Villegas Valverde
Publikováno v:
MOJ Immunology. 4
Background: Ovarian carcinoma (OC) is one of the most severe and lethal cancers in women. Regulatory T (Treg) cells may participate in mediating a suppressive microenvironment in tumor tissue and contribute to tumor evasion from immune response. Spec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::652f471c874999226c95915b60fc55fa
https://doi.org/10.15406/moji.2016.04.00139
https://doi.org/10.15406/moji.2016.04.00139
Autor:
Sonia Franco-Odio, Vicente Madrid-Marina, Reyes Tamez-Guerra, Juan Manuel Alcocer-González, Marta Elena Guerra-Yi, Cristina Rodríguez-Padilla, Leticia Llanes-Fernández, Rolando Camacho-Rodríguez, Maria del Carmen Arango-Prado
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 135:255-264
Breast cancer patients may express abnormal cellular immune responses affecting their immunological competence. The analysis of immunological parameters may be useful as indicators of T cell function. To determine the expression of lymphocyte activat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11093d67f252e90a910fb2c7a2873df9
https://doi.org/10.1007/s00432-008-0446-7
https://doi.org/10.1007/s00432-008-0446-7
Autor:
Reyes Tamez-Guerra, Rolando Camacho-Rodríguez, Rosa Irene Álvarez-Goyanes, Vicente Madrid-Marina, Leticia Llanes-Fernández, Sonia Franco Odio, Maiby Orozco López, Juan Manuel Alcocer-González, Marta Elena Guerra-Yi, Julia Cruz Mojarrieta, Maria del Carmen Arango-Prado, Xiomara Escobar Pérez, Cristina Rodríguez-Padilla
Publikováno v:
The Breast. 15:482-489
Tumor markers are expressed due to molecular alterations of the tumor cells, and we can relate them to the immune system to find new associations to improve prognosis. IL-10 inhibits the generation of immune responses at the tumor site. To determine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5eca11164a43e3604743003656593b70
https://doi.org/10.1016/j.breast.2005.09.012
https://doi.org/10.1016/j.breast.2005.09.012
Autor:
Marta Osorio, Elías Gracia, Edmundo Rodríguez, Giselle Saurez, Maria del Carmen Arango, Elena Noris, Adriana Torriella, Alejandro Joan, Erasmo Gómez, Lorenzo Anasagasti, Jorge Luis González, María de los Angeles Melgares, Imilla Torres, Joel González, Dayamí Alonso, Enrique Rengifo, Adriana Carr, Rolando Pérez, Luis Enrique Fernández
Publikováno v:
Cancer biologytherapy. 7(4)
NeuGcGM3 ganglioside is especially attractive because it is expressed on melanoma cells but it is minimally or not expressed at all on most normal human tissues. A Phase Ib/IIa clinical trial was carried out in patients with advanced cutaneous and oc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a17d5a474c7ca26ac6074e56e739039d
https://pubmed.ncbi.nlm.nih.gov/18285705
https://pubmed.ncbi.nlm.nih.gov/18285705
Autor:
Mark M Landeros, Carmen Arango, Angel Campos-Gines, Ethan Reiter, Nicole Maxey, Pamela Dominguez-Perez, Matilde Gonzalez, Elena Morales, Anuradha Gupta, Nishaal Antony, Erasto Cortes, Zeinab Mohammadi, Juan Herrada, Javier Gutierrez
Publikováno v:
Blood. 126:4633-4633
Background: Lymphoid tissue hyperplasia has been described in oncologic patients after receiving chemotherapy at different sites including: adenoids, tonsils, nasopharynx and thymus. Thymic hyperplasia has been reported more frequently in the pediatr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c9f52245e5913e88647f30f7a7e8f0f
https://doi.org/10.1182/blood.v126.23.4633.4633
https://doi.org/10.1182/blood.v126.23.4633.4633